Szakirodalom
Autovakcinákkal kapcsolatos szakirodalom
(válogatás az állatorvoslás területéről)
Anderson J. F., Werdin R. E., Bates F. Y. (1980): A modified Kohler technique of producing autogenous oral vaccine for swine. Vet. Med. Small Anim. Clin., 75(2):293-296.
Angyal T., Laczay A., Csapó K. (1967): Clinical and serological observations on autogenous and heterogenous vaccination in staphylococcal skin diseases. Acta Microbiol. Acad. Sci. Hung., 14(2):223-230.
Arora A. K., Killinger A. H., Mansfield M. E. (1976): Bacteriologic and vaccination studies in a field epizootic of infectious bovine keratoconjunctivitis in calves. Am. J. Vet. Res., 37(7):803-805.
Baums C. G., Brüggemann C., Kock C., Beineke A., Waldmann K. H., Valentin-Weigand P. (2010): Immunogenicity of an autogenous Streptococcus suis bacterin in preparturient sows and their piglets in relation to protection after weaning. Clin. Vaccine Immunol., 17(10):1589-1597.
Bayer M., Steinbach W., Weiss E.-W. (1995): Orale E. coli-Autovakzine beim Pferd. Prakt. Tierarzt, 206-212.
Bertl F., Weiss H.-E. (1991): Therapie antibiotikaresistenter E. coli-Enteritiden bei Hunden und Katzen durch oral applizierte Autovakzinen. Prakt. Tierarzt., 12-14.
Bierer B. W., Eleazer T. H. (1968): Comparative efficacy of commercial fowl cholera bacterins and autogenous bacterin in White Leghorn hens artificially infected with Pasteurella multocida. Poult. Sci., 47(4):1162-1165.
Bulgin M. S., Bruss M. L., Anderson B. C. (1990): Methods for control of lamb epididymitis in large purebred flocks. J. Am. Vet. Med. Assoc., 196(7):1110-1115.
Busque P., Higgins R., Caya F., Quessy S. (1997): Immunization of pigs against Streptococcus suis serotype 2 infection using a live avirulent strain. Can. J. Vet. Res., 61(4):275-279.
Chirino-Trejo M., Woodbury M. R., Huang F. (2003): Antibiotic sensitivity and biochemical characterization of Fusobacterium spp. and Arcanobacterium pyogenes isolated from farmed white-tailed deer (Odocoileus virginianus) with necrobacillosis. J. Zoo. Wildl. Med., 34(3):262-268.
Chukiatsiri K., Sasipreeyajan J., Neramitmansuk W., Chansiripornchai N. (2009): Efficacy of autogenous killed vaccine of Avibacterium paragallinarum. Avian Dis., 53(3):382-386.
Clark B. L., Stewart D. J., Emery D. L., Dufty J. H., Jarrett R. G. (1986): Immunisation of cattle against interdigital dermatitis (foot-rot) with an autogenous Bacteroides nodosus vaccine. Aust. Vet. J., 63(2):61-62.
Coffman J. R., Finocchio E. J. (1969): Autogenous bacterins in the treatment of osteomyelitis in the horse. Vet. Med. Small. Anim. Clin., 64(10):899-902.
Curtis C. F., Lamport A. I., Lloyd D. H. (2006): Masked, controlled study to investigate the efficacy of a Staphylococcus intermedius autogenous bacterin for the control of canine idiopathic recurrent superficial pyoderma. Vet. Dermatol., 17(3):163-168.
Czernomysy-Furowicz D., Fijałkowski K., Silecka A., Karakulska J., Nawrotek P., Drozd R., Ferlas M., Borkowski J., Jankowiak D. (2014): Herd-specific autovaccine and antibiotic treatment in elimination of Staphylococcus aureus mastitis in dairy cattle. Turk. J. Vet. Anim. Sci., 38:496-500.
Davison S., Benson C. E., Henzler D. J., Eckroade R. J. (1999): Field observations with Salmonella enteritidis bacterins. Avian Dis., 43(4):664-669.
D. M. L., Githigia S. M., P. C., H. M. A, J. M K. (2012): Manangement of bovine paillomatosis using an autogenous vaccine: A case study in Bukura Agricultural College, western Kenya. Biennial Scientific Conference, 8(12):39.
Funk L., O’Connor A. M., Maroney M., Engelken T., Cooper V. L., Kinyon J., Plummer P. (2009): A randomized and blinded field trial to assess the efficacy of an autogenous vaccine to prevent naturally occurring infectious bovine keratoconjunctivis (IBK) in beef calves. Vaccine., 27(34):4585-4590.
Guo-dong F., Xiao-chang X., Mei-li G., Xian-feng W., Zhen S., Nan M., Yuan G., Zeng-lu W., Qiang H., Wei-na L., Meng L., Cun Z., Wei Z., Ying-qi Z. (2014): Therapeutic effects of PADRE-BAFF autovaccine on rat adjuvant arthritis. Biomed. Res. Int., 1-9.
Gurung R. B., Dhungyel O. P., Tshering P., Egerton J. R. (2006): The use of an autogenous Dichelobacter nodosus vaccine to eliminate clinical signs of virulent footrot in a sheep flock in Bhutan. Vet. J., 172(2):356-363.
Halbur P., Thanawongnuwech R., Brown G., Kinyon J., Roth J., Thacker E., Thacker B. (2000): Efficacy of antimicrobial treatments and vaccination regimens for control of porcine reproductive and respiratory syndrome virus and Streptococcus suis coinfection of nursery pigs. J. Clin. Microbiol., 38(3):1156-1160.
Hartman P. A., Jacobson N. L. (1971): Immunization with autogenous rumen enterococci. Can. J. Microbiol., 17(10):1339-1341.
Hera A., Bures J. (2004): Veterinary autogenous vaccines. Dev. Biol., 117:19-25.
Hinton M. (1977): Treatment of purulent staphylococcal conjunctivitis in rabbits with autogenous vaccine. Lab. Anim., 11(3):163-164.
Hoedemaker M., Korff B., Edler B., Emmert M., Bleckmann E. (2001): Dynamics of Staphylococcus aureus infections during vaccination with an autogenous bacterin in dairy cattle. J. Vet. Med. B Infect. Dis. Vet. Public Health, 48(5):373-383.
House J. K., Ontiveros M. M., Blackmer N. M., Dueger E. L., Fitchhorn J. B., McArthur G. R., Smith B. P. (2001): Evaluation of an autogenous Salmonella bacterin and a modified live Salmonella serotype Choleraesuis vaccine on a commercial dairy farm. Am. J. Vet. Res., 62(12):1897-1902.
Hughes D. E., Kohlmeier R. H., Pugh G. W. Jr., Booth G. D. (1979): Comparison of vaccination and treatment in controlling naturally occurring infectious bovine keratoconjunctivitis. Am. J. Vet. Res., 40(2):241-244.
Hughes D. E., Pugh G. W. Jr., Kohlmeier R. H., Booth G. D., Knapp B. W. (1976): Effects of vaccination with a Moraxella bovis bacterin on the subsequent development of signs of corneal disease and infection with M. bovis in calves under natural environmental conditions. Am. J. Vet. Res., 37(11):1291-1295.
Inayat A., Muhammed G., Asi M.N., Saqib M., Athar M. (1999): Use of autogeneous vaccine for the treatment of generalized papillomatosis in cattle. Pak. Vet. J., 19(2):102-103.
Jokiel J. (2009): Untersuchungen zur Sanierung von Staphylococcus aureus-Mastitiden mittels stallspezifischer Vakzinen in Schaf- und Ziegenherden. Hannover, Tierärztliche Hochschule, Dissertation.
Kaplan L. (1993): Autogenous vaccination against Helicobacter pylori. S. Afr. Med. J., 83(12):922-923.
Kostro K., Lisiecka U., Zmuda A., Niemczuk K., Stojecki K., Taszkun I. (2014): Selected parameters of immune response in pregnant sows vaccinated against Trueperella pyogenes. Bull. Vet. Inst Pulawy., 58:17-21.
Marschang F., Morscher H., Weiss H.-E., Wacker R. (1990): Zum Problem Respirationssyndrom des Rindes, aus dem Blickwinkel der Praxis. 1. Mitteilung. Bestandserkrankungen und Gegenmaß-nahmen, Tierarztl. Umsch., 465-470.
Marschang F., Morscher H., Weiss H.-E., Wacker R. (1990): Zum Problem Respirationssyndrom des Rindes, aus dem Blickwinkel der Praxis. 2. Mitteilung. Einsatz stallspezifischer Pasteurellen-Vakzinen, Tierarztl. Umsch., 608-613.
Marschang F., Weiss H.-E. (1993): Einsatz von stallspezifischen Pasteurellavakzinen als Notimpfung auch bei Kühen sinn- und wirkungsvoll. Prakt. Tierarzt., 1013-1016.
Marschang F., Weiss H.-E. (1990): Stallvakzine kontra Pasteurellenerkrankungen – Ein Fallbericht, Tierarztl. Umsch., 279-283.
Matherne C. M., Steffen E. K., Wagner J. E. (1987): Efficacy of commercial vaccines for protecting guinea pigs against Bordetella bronchiseptica pneumonia. Lab. Anim. Sci., 37(2):191-194.
Mouahid M., Bouzoubaa K., Zouagui Z. (1991): Preparation and use of an autogenous bacterin against infectious coryza in chickens. Vet. Res. Commun., 15(6):413-419.
Pascu C., Herman V., Costinar L. (2008): Evaluation of the immune postvaccinal response after administration of the autovaccine anti Actinobacillus pleuropneumoniae. Lucr. Şt. Med. Vet., 41:888-891.
Perry J. M. (1982): Autogenous E coli bacterins for swine. Mod. Vet. Pract., 63(9):721.
Pomeroy B. S., Nagaraja K. V., Ausherman L. T., Peterson I. L., Friendshuh K. A. (1989): Studies on feasibility of producing Salmonella-free turkeys. Avian Dis., 33(1):1-7.
Pugh G. W. Jr., Hughes D. E., Booth G. D. (1978): Serologic response of vaccinated cattle to strains of Moraxella bovis isolated during epizootics of keratoconjunctivitis. Am. J. Vet. Res., 39(1):55-57.
Santos Y., García-Marquez S., Pereira P. G., Pazos F., Riaza A., Silva R., El Morabit A., Ubeira F. M. (2005): Efficacy of furunculosis vaccines in turbot, Scophthalmus maximus (L.): evaluation of immersion, oral and injection delivery. J. Fish Dis., 28(3):165-172.
Smart N. L., Hurnik D., Macinnes J. I. (1993): An investigation of enzootic Glasser’s disease in a specific-pathogen-free grower-finisher facility using restriction endonuclease analysis. Can. Vet. J., 34(8):487-490.
Srivastava S. K., Barnum D. A. (1981): The serological response of foals to vaccination against strangles. Can. J. Comp. Med., 45(1):20-25.
Storey R. C., Stoddard P., Barger R. (1977): An autogenous vaccine in successful treatment of infectious keratitis in cattle. Vet. Med. Small Anim. Clin., 72(6):1050-1055.
Vielitz E., Conrad C., Voss M., Löhren U., Bachmeier J., Hahn I. (1992): Immunizing against salmonella infections with live and inactivated vaccines. Dtsch. Tierarztl. Wochenschr., 99(12):483-485.
Wambura P. N. (2009): Preparation and use of autogenous vaccine from Avibacterium paragallinarum (strain Tan 1-05) in layer chickens. Trop Anim Health Prod., 42(3):483-486.
Wood B. J. (1967): Chronic staphylococcic infection in allergic rhinitis: treatment with autogenous vaccine. Ann. Allergy., 25(10):587-590.
Autovakcinák a humán medicinában
(válogatás az utóbbi néhány év szakirodalmából)
Bocci V., Travagli V., Zanardi I. (2009): The failure of HIV vaccines: A new autovaccine may overcome some problems. Med. Hypotheses, 72(6):662-664.
Bocci V., Zanardi I., Travagli V. (2010): Ozonation of human HIV-infected plasmas for producing a global vaccine: How HIV-patients may help fight the HIV pandemia. Virulence, 1(3):215-217.
Chylak J. (2000): Autovaccines as protection against successive acute pharyngitis and tonsillitis in children. Int. Rev. Allergol. Clin. Immunol., 6(1):27-31.
Das A. M., Paranjape V. L. (1988): Autogenous vaccine therapy in human cutaneous staphylococcosis. Indian J. Med. Res., 88:404-408.
De Vito D., Mastrorillo G., Rizzo G. (2002): Trattamento con autovaccino delle osteomieliti croniche. Ig. Mod., 118:267-274.
Gallego-Vilar D., Sanchis-Verdu L., Beltran Persiva J., Cunat-Albert E., Cervello-Grima E., Gallego-Gomez J., Perez-Mestre M. (2014): Autovaccines for chronic urinary tract infections; ten years follow-up experience. Am J Life Sci., 2(6-3):13-17.
Hałasa J., Hałasa M., Wojciechowska W., Podkowińska I., Kucharska E. (2001): Clinical efficacy of autovaccine in the treatment of infectious nonatopic asthma and COPD – double blind placebo controlled trial. Alerg. Astma Immun., 6(2):109-113.
Kazhyna M. V., Pozniak S. B. (2002): Autovaccinotherapia in females with genital chronic infection: multicentered analysis. Immunol. Allerg. Infect., 4:45-53.
Kutsyk R. V., Kurovets’ L. M. (2002): Species composition and antibiotic sensitivity of staphylococci isolated from patients with furunculosis. Mikrobiol. Z., 64(5):59-62.
Monno R., DeVito D., Ceci G., Costi A., Coscia F., de Nicolò T., Rizzo G. (2003): Comparative evaluation of test assays for detection of methicillin resistance in Staphylococcus aureus. Clin. Microbiol. Infect., 9(6):574-575.
Nolte O. (2001): Autovaccine – Ein Überblick. Mikrobiologie, 11:11-16.
Nolte O. (2009): Zur Diskussion: Die autogene Vakzination als nicht-antimikrobielles Verfahren bei Therapie-resistenten bakteriellen Infektionen – Bedeutung als alternative Behandlungsoption in Zeiten zunehmender antimikrobieller Resistenzproblematik. Chemother. J., 18(1):18-23.
Nolte O., Haag H., Zimmermann A., Geiss H. K. (2005): Staphylococcus aureus positive for Panton-Valentine leukocidin genes but susceptible to methicillin in patients with furuncles. Eur. J. Clin. Microbiol. Infect. Dis., 24(7):477-479.
Nolte O., Thrull R. (2010): Die autogene Vakzine zur Behandlung chronisch-rezidivierender Infektionen – Evaluierung der Wirksamkeit und Verträglichkeit in deutschen Arztpraxen. MMW Fortschr. Med. Orig. Ergänzungsband. I., 152:30-36.
Prowans P., Zyluk A., Grzeszewski S. (2004): Results of Kirschner wire osteosynthesis and intramedullary bone peg in toe-transfers. Chir. Narzadow Ruchu. Ortop. Pol., 69(1):15-17.
Rizzo C., Brancaccio G., De Vito D., Rizzo G. (2007): Efficacy of autovaccination therapy on post-coronary artery bypass grafting methicillin-resistant Staphylococcus aureus mediastinitis. Interact. Cardiovasc. Thorac. Surg., 6(2):228-229.
Rusch V., Ottendorfer D., Zimmermann K., Gebauer F., Schrödl W., Nowak P., Skarabis H., Kunze R. (2001): Results of an open, non-placebo controlled pilot study investigating the immunomodulatory potential of autovaccine. Arzneimittelforschung, 51(8):690-697.
Thrull R. (2000): Acne fulminans: Behandlung mit Autovakzinen. Deutsch Ärztebl., 97(51-52):A-3510.
Thrull R. (2000): Parodontitis marginalis und kardiovaskuläre Erkrankungen. Deutsch Ärztebl., 97(6):A-323.
Thrull R. H., Lott R. (2005): Bedrohliche Zunahme Methicillin-resistenter Staphylococcus-aureus-Stämme: Nebenwirkungsfreie Immunisierung. Deutsch Ärztebl., 102(15):A-1069.
Uyttenhove C., van Snick J. (2006): Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis. Eur. J. Immunol., 36:2868–2874.
Waterston A. M., Salway F., Andreakos E., Butler D.M., Feldmann M., Coombes R.C. (2004): TNF autovaccination induces self anti-TNF antibodies and inhibits metastasis in a murine melanoma model. Br. J. Cancer, 90:1279–1284.